Overview

Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain

Status:
Withdrawn
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The aim of this proposal is to characterize pain inhibition in healthy controls and Temporomandibular Disorder (TMD) patients with two models of endogenous pain modulation (off-set analgesia; conditioned pain modulation), and to investigate the function of the endogenous opioid system in these responses by using pharmacological blockade of the opioid receptor.
Phase:
N/A
Details
Lead Sponsor:
University of Florida
Collaborator:
American Pain Society
Treatments:
Naltrexone